- Home
- ALM vs AUPH Comparison
ALM vs AUPH Comparison
Compare ALM & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALM
- AUPH
- Stock Information
- Founded
- ALM N/A
- AUPH 1993
- Country
- ALM Canada
- AUPH Canada
- Employees
- ALM N/A
- AUPH N/A
- Industry
- ALM Other Metals and Minerals
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- ALM Basic Materials
- AUPH Health Care
- Exchange
- ALM Nasdaq
- AUPH Nasdaq
- Market Cap
- ALM 1.5B
- AUPH 1.6B
- IPO Year
- ALM N/A
- AUPH 1999
- Fundamental
- Price
- ALM $5.60
- AUPH $15.72
- Analyst Decision
- ALM Strong Buy
- AUPH Strong Buy
- Analyst Count
- ALM 2
- AUPH 3
- Target Price
- ALM $12.00
- AUPH $17.67
- AVG Volume (30 Days)
- ALM 2.0M
- AUPH 2.2M
- Earning Date
- ALM 11-03-2025
- AUPH 11-04-2025
- Dividend Yield
- ALM N/A
- AUPH N/A
- EPS Growth
- ALM N/A
- AUPH N/A
- EPS
- ALM N/A
- AUPH 0.55
- Revenue
- ALM $21,591,798.00
- AUPH $265,808,000.00
- Revenue This Year
- ALM $108.36
- AUPH $17.33
- Revenue Next Year
- ALM $169.35
- AUPH $14.31
- P/E Ratio
- ALM N/A
- AUPH $28.50
- Revenue Growth
- ALM 7.50
- AUPH 20.62
- 52 Week Low
- ALM $0.89
- AUPH $6.55
- 52 Week High
- ALM $10.68
- AUPH $16.20
- Technical
- Relative Strength Index (RSI)
- ALM 37.06
- AUPH 71.08
- Support Level
- ALM $5.87
- AUPH $14.93
- Resistance Level
- ALM $6.55
- AUPH $15.81
- Average True Range (ATR)
- ALM 0.47
- AUPH 0.81
- MACD
- ALM -0.16
- AUPH 0.03
- Stochastic Oscillator
- ALM 7.59
- AUPH 83.39
About ALM Almonty Industries Inc. Common Shares
Almonty Industries Inc is engaged in the mining, processing, and shipping of tungsten concentrate from its Los Santos tungsten mine located near Salamanca, Spain - the Los Santos Mine, the processing and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal - the Panasqueira Mine, the evaluation of its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora - the Valtreixal Mine, as well as the exploration and evaluation of its Sangdong tungsten mine project located in Gangwon Province, Republic of Korea - the Sangdong Mine.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.